Nanjing: 47 pharmaceutical companies have been informed to negotiate prices. If they don't go, they will "pull black"
-
Last Update: 2018-02-06
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: sabilan 2018-02-06, Nanjing health and Family Planning Commission issued the first batch of drug price negotiation announcement of medical institutions in Nanjing According to the announcement, Nanjing will organize medical institutions to carry out the first batch of drug price negotiations This time, the relevant bidding enterprises will be notified to appoint two negotiation representatives to participate in the price negotiations at room 1201, floor 2, No 3 (Nanjing public health emergency command center), zizhulin, Nanjing, at 8:30 a.m on February 8, with the letter of authorization, ID card of the authorized person and copies The key point is that the Nanjing health and Family Planning Commission said: those who do not participate in the price negotiation are deemed to have given up the qualification of centralized purchase of drugs by medical institutions in Nanjing, and the enterprises are listed in the list of bad credit records It means that relevant pharmaceutical companies must talk about it, or they will be listed in the list of bad credit records The price of being "blackmailed" is that within a cycle, Nanjing will no longer purchase its drugs ▍ 57 drugs, 47 pharmaceutical companies There are 57 drugs in this notice, involving 47 pharmaceutical companies When industry media reported earlier, the list given was 63 drugs In response, the Nanjing health and Family Planning Commission made a statement that "the catalogue has been adjusted, subject to the notice on adjusting the first batch of drug catalogue for price negotiation of medical institutions in Nanjing" There is no doubt that this negotiation is mainly about price Will the price rise? No, it's quite possible to reduce the price If we can guarantee the sales volume of 57 drugs, it is not unacceptable to reduce the price What we are most worried about is that we only talk about the price, not the sales volume, which is not an easy thing It sounds like a standard secondary bargaining Previously, Zhengzhou health and Family Planning Commission issued a document saying that secondary bargaining should be carried out, and sabilan has also made reports, but the industry feedback is not fierce and there are few comments I'm afraid it's a common occurrence, and it's not surprising for practitioners The date of the notice is February 8 We hope that the 57 drugs will have good results Annex: if there is any adjustment to the catalogue, the notice on adjusting the catalogue of the first batch of drugs for price negotiation of medical institutions in Nanjing shall prevail The catalogue is as follows:
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.